Skip to content

Study · Not a test of the peptide alone · 1996

1 result

Cross-link between cys 374 and cys 10 of actin abolishes polymerizability and allows study of the properties of the "F-actin monomer".

Heintz D, Faulstich H

Biochemistry1 Jan 1996Cited by 3 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Activity measurement

    In purified protein tests, cross-linked actin bound thymosin beta‑4, as shown by cross-linking studies.

    In plain wordsIn lab tests, cross-linked actin still bound thymosin beta‑4. This result describes the modified actin.

    Outcome
    Not applicableBinding of thymosin beta 4 by cross-linked actin
    Study

    n: not reported in source

    purified proteins
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Cross-linked actin inhibits DNase I to the same extent as G-actin and binds thymosin beta 4 and profilin as shown by cross-linking studies.
    1 context sentence
    Summary · context
    Actin cross-linked between cys 374 and cys 10 via a disulfide-containing bridge, c-A, is completely unpolymerizable even in the presence of phalloidin.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.